Neovacs S.Aの浮動株式数
Neovacs S.Aの浮動株式数は何ですか。
Neovacs S.A.の浮動株式数は176.163M 0.88%です。
浮動株式数の定義は何ですか。
浮動株式数は、ロックインされた株式とは対照的に、公的投資家の手にある企業の株式の一部です。
Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded
The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.
EURONEXTのセクタHealth Careにおける浮動株式数の企業と比べるNeovacs S.A
Neovacs S.Aは何をしますか。
Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for chronic autoimmune and inflammatory diseases using its proprietary Kinoid technology. The company's product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of systemic lupus erythematosus; Phase IIa clinical trial for the treatment of dermatomyositis; and preclinical stage for the treatment of diabetes. It is also developing VEGF-Kinoid, which is in preclinical stage for the treatment of age-related macular degeneration and solid tumors; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company has a collaboration with the Sunnybrook Research Institute for preclinical development of VEGF Kinoid to treat colorectal and ovarian cancer. Neovacs S.A. was founded in 1993 and is based in Paris, France.
Neovacs S.Aと類似の浮動株式数
- Spectral Medicalの浮動株式数は176.036M 65.71%です。
- Applied Energeticsの浮動株式数は176.036M 84.81%です。
- Alcoaの浮動株式数は176.070M 94.41%です。
- Ascentage Pharma Internationalの浮動株式数は176.112M 66.79%です。
- Taisho Pharmaceutical Coの浮動株式数は176.131M 55.17%です。
- Cobalt Blockchainの浮動株式数は176.157M 81.10%です。
- Neovacs S.Aの浮動株式数は176.163M 0.88%です。
- MedX Health Corpの浮動株式数は176.181M 95.91%です。
- The Stanley Gibbons plcの浮動株式数は176.210M 41.27%です。
- The Stanley Gibbons plcの浮動株式数は176.210M 41.27%です。
- Continentalの浮動株式数は176.251M 25.80%です。
- Silver Spruce Resourcesの浮動株式数は176.338M 94.78%です。
- XLMedia PLCの浮動株式数は176.382M 67.17%です。